PARAPRO LLC FDA Approval NDA 022408

NDA 022408

PARAPRO LLC

FDA Drug Application

Application #022408

Documents

Letter2015-01-07
Label2011-01-19
Summary Review2011-02-17
Letter2011-01-20
Label2015-01-05
Review2011-02-16
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Pediatric Statistical Review1900-01-01
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Letter2021-04-30
Label2021-05-03
Pediatric Other1900-01-01

Application Sponsors

NDA 022408PARAPRO LLC

Marketing Status

Prescription001

Application Products

001SUSPENSION;TOPICAL0.9%1NATROBASPINOSAD

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2011-01-18STANDARD
EFFICACY; EfficacySUPPL5AP2014-12-30STANDARD
LABELING; LabelingSUPPL8AP2021-04-28STANDARD
EFFICACY; EfficacySUPPL10AP2021-04-28STANDARD

Submissions Property Types

ORIG1Null7
SUPPL5Null6
SUPPL8Null6
SUPPL10Null7

CDER Filings

PARAPRO LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 22408
            [companyName] => PARAPRO LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NATROBA","activeIngredients":"SPINOSAD","strength":"0.9%","dosageForm":"SUSPENSION;TOPICAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"12\/30\/2014","submission":"SUPPL-5","supplementCategories":"Efficacy-Pediatric","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/022408s005lbl.pdf\"}]","notes":""},{"actionDate":"01\/18\/2011","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/022408lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"NATROBA","submission":"SPINOSAD","actionType":"0.9%","submissionClassification":"SUSPENSION;TOPICAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2014-12-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.